ConductScience.org, home

Paper41316360

LncRNA LEF1-AS1 exerts a carcinogenic effect in breast cancer by accelerating proliferation, metastasis, and epithelial-mesenchymal transition.

Kong L and 3 others. Hereditas, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. LncRNA LEF1-AS1 exerts a carcinogenic effect in breast cancer by accelerating proliferation, metastasis, and epithelial-mesenchymal transition. Papers, record 41316360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41316360

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LncRNA LEF1-AS1 exerts a carcinogenic effect in breast cancer by accelerating proliferation, metastasis, and epithelial-mesenchymal transition.
PubMed
Journal
Hereditas
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-06-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kong LLinna
2Liu JJiaqi
3Zhang HHuihui
4Chu JJun

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epithelial-Mesenchymal TransitionMajor topic
Breast NeoplasmsMajor topic
RNA, Long NoncodingMajor topic
Lymphoid Enhancer-Binding Factor 1Major topic
CarcinogenesisMajor topic
Humans
Cell Proliferation
Female
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Cell Movement
MicroRNAs
Neoplasm Metastasis
Apoptosis

Source PubMed

Download CSV of topics

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140540857Advancements in liquid biopsy for breast Cancer: Molecular biomarkers and clinical applications.Cancer Treat Rev2025https://conductscience.org/library/papers/40540857PubMed
239261346LncRNA XIST/miR-455-3p/HOXC4 axis promotes breast cancer development by activating TGF-β/SMAD signaling pathway.Funct Integr Genomics2024https://conductscience.org/library/papers/39261346PubMed
332099465LncRNA LEF1-AS1 Promotes Ovarian Cancer Development Through Interacting with miR-1285-3p.Cancer Manag Res2020https://conductscience.org/library/papers/32099465PubMed
435371339lncRNA LEF1-AS1 Acts as a Novel Biomarker and Promotes Hypopharyngeal Squamous Cell Carcinoma Progression and Metastasis by Targeting the miR-221-5p/GJA1 Axis.Dis Markers2022https://conductscience.org/library/papers/35371339PubMed
527444227Non-coding RNAs as drug targets.Nat Rev Drug Discov2017https://conductscience.org/library/papers/27444227PubMed
636276461A systems biology investigation of curcumin potency against TGF-β-induced EMT signaling in lung cancer.3 Biotech2022https://conductscience.org/library/papers/36276461PubMed
735743249Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.Int J Mol Sci2022https://conductscience.org/library/papers/35743249PubMed
831599448Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.Eur Rev Med Pharmacol Sci2019https://conductscience.org/library/papers/31599448PubMed
930147992Tomosynthesis-Guided Core Biopsy of the Breast: Why and How to Use it.J Clin Imaging Sci2018https://conductscience.org/library/papers/30147992PubMed
1035796007Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer.Int J Mol Med2022https://conductscience.org/library/papers/35796007PubMed
1130734202LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.Invest New Drugs2019https://conductscience.org/library/papers/30734202PubMed
1223237552On the origin of cancer metastasis.Crit Rev Oncog2013https://conductscience.org/library/papers/23237552PubMed
1329516641Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.J Cell Mol Med2018https://conductscience.org/library/papers/29516641PubMed
1435013579Non-coding RNAs as liquid biopsy biomarkers in cancer.Br J Cancer2022https://conductscience.org/library/papers/35013579PubMed
1539323334Revealing the Molecular Signatures of miR-185-5p on Breast Cancer Cells Using Proteomic Analysis.Protein Pept Lett2024https://conductscience.org/library/papers/39323334PubMed
1639323624Beyond the Genome: Deciphering the Role of MALAT1 in Breast Cancer Progression.Curr Genomics2024https://conductscience.org/library/papers/39323624PubMed
1737666286miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers.Cell Signal2023https://conductscience.org/library/papers/37666286PubMed
1833292271LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway.Cancer Cell Int2020https://conductscience.org/library/papers/33292271PubMed
1931536481Two Novel Long Noncoding RNAs - RP11-296E3.2 and LEF1-AS1can - Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer.Med Sci Monit2019https://conductscience.org/library/papers/31536481PubMed
2038284731Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms.Curr Mol Pharmacol2024https://conductscience.org/library/papers/38284731PubMed

See all 43 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
LEF1-AS1641518PubTator's text mininghttps://conductscience.org/library/genes/641518

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41316360

GET https://conductscience.org/api/papers/v1/41316360/references?page=2